Back
Bristol-Myers Squibb 10K Form
Sell
43
BMY
Bristol-Myers Squibb
Last Price:
55.94
Seasonality Move:
1.69%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive BMY News And Ratings
See the #1 stock for the next 7 days that we like better than BMY
BMY Financial Statistics
Sales & Book Value
Annual Sales: | $45.01B |
---|---|
Cash Flow: | $5.27B |
Price / Cash Flow: | 8.22 |
Annual Sales: | $8.45 |
Price / Book: | 6.62 |
Profitability
EPS (TTM): | -3.59000 |
---|---|
Net Income (TTM): | $-7.26B |
Gross Margin: | $34.31B |
Return on Equity: | -33.18% |
Return on Assets: | -7.66% |
Bristol-Myers Squibb Earnings Forecast
Key Bristol-Myers Squibb Financial Ratios
- The Gross Profit Margin over the past 37 years for BMY is 76.24%.
- The Selling, General & Administrative Expenses for BMY have been equal to 17.27% of Gross Profit Margin.
- The Research & Development expenses have been 20.66% of Revenue.
- The Interest Expense is 14.53% of Operating Income.
- The Net Earning history of BMY is 17.83% of Total Revenues.
- Per Share Earnings over the last 37 years have been positive in 19 years.
Bristol-Myers Squibb Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | S&P500 |
---|---|
Industry: | Pharmaceuticals |
Sector: | Health Care |
Current Symbol: | BMY |
CUSIP: | 110122 |
Website: | bms.com |
Debt
Debt-to-Equity Ratio: | 2.9 |
---|---|
Current Ratio: | 1.24 |
Quick Ratio: | 1.02 |
Price-to-Earnings
Trailing P/E Ratio: | 14.49 |
---|---|
Forward P/E Ratio: | 7.94 |
BMY Technical Analysis vs Fundamental Analysis
Sell
43
Bristol-Myers Squibb (BMY)
is a Sell
Is Bristol-Myers Squibb a Buy or a Sell?
-
Bristol-Myers Squibb stock is rated a Sell
The current Bristol-Myers Squibb [BMY] share price is $55.95. The Score for BMY is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.